Kainos Group plc Director/PDMR Shareholding (2338X)

TIDMKNOS

RNS Number : 2338X

Kainos Group plc

08 August 2018

08 August 2018

Kainos Group plc

("Kainos" or the "Company)

Director / PDMR Dealing

The Company was notified on the 08 August 2018, that Brendan Mooney, CEO, exercised his 2015 PSP options over 98,921 ordinary shares of GBP0.005 in the Company ("Ordinary Shares"), at an exercise price of GBP0.005 per Ordinary Share.

Brendan Mooney retained the Ordinary Shares on exercise.

Following this notification, Brendan Mooney and his Person Closely Associated (PCA) have a reportable shareholding of 14,205,941 Ordinary Shares in the issued share capital of the Company, constituting 11.88% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a.   Name                            Brendan Mooney 
     ------------------------------  ------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------- 
 a.   Position/status                 CEO/PDMR 
     ------------------------------  ------------------------------------------- 
 b.   Initial notification            Initial notification 
       /Amendment 
     ------------------------------  ------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     --------------------------------------------------------------------------- 
 a.   Name                            Kainos Group plc 
     ------------------------------  ------------------------------------------- 
 b.   LEI                             213800H2PQMIF3OVZY47 
     ------------------------------  ------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     --------------------------------------------------------------------------- 
 a.   Description of                  Ordinary Shares of GBP0.005 each 
       the 
       Financial instrument/ 
       type of instrument              ISIN: GB00BZ0D6727 
       Identification 
       code 
     ------------------------------  ------------------------------------------- 
 b.   Nature of the transaction       Exercise of 2015 PSP Options and retention 
                                       of shares 
     ------------------------------  ------------------------------------------- 
 c.   Price(s) and volume(s)           Price(s)    Volume(s) 
                                        GBP0.005    98,921 
                                                   ---------- 
     ------------------------------  ------------------------------------------- 
 d.        Aggregated information 
             *    Aggregated volume     N/A 
 
 
             *    Price 
     ------------------------------  ------------------------------------------- 
 e.   Date of the transaction         08 August 2018 
     ------------------------------  ------------------------------------------- 
 f.   Place of the transaction        Outside a trading venue 
     ------------------------------  ------------------------------------------- 
 

Classification: Additional Regulated Information

Ends

For further information, please contact:

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc 44 20 7597 5970

Patrick Robb / Sebastian Lawrence

Canaccord Genuity [phone]

Simon Bridges / Emma Gabriel

FTI Consulting LLP [phone]

Matt Dixon / Harry Staight

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFKFDDNBKDFFK

(END) Dow Jones Newswires

August 08, 2018 09:20 ET (13:20 GMT)